CIBC World Market
JAZZ icon

CIBC World Market’s Jazz Pharmaceuticals JAZZ Stock Holding History

CIBC World Market’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$491K Sell
2,597
-45
-2% -$7.86K ﹤0.01% 1135
2025
Q4 		$449K Sell
2,642
-260
-9% -$39.9K ﹤0.01% 1155
2025
Q3 		$382K Buy
2,902
+588
+25% +$70.5K ﹤0.01% 1170
2025
Q2 		$246K Buy
2,314
+80
+4% +$8.69K ﹤0.01% 1230
2025
Q1 		$277K Buy
+2,234
New +$291K ﹤0.01% 1183
2023
Q3 		– Sell
-16,717
Closed -$2.07M – 1247
2023
Q2 		$2.07M Buy
16,717
+4,166
+33% +$561K 0.01% 583
2023
Q1 		$1.84M Sell
12,551
-721
-5% -$107K 0.01% 607
2022
Q4 		$2.11M Sell
13,272
-1,952
-13% -$286K 0.01% 563
2022
Q3 		$2.03M Sell
15,224
-270
-2% -$41.1K 0.01% 539
2022
Q2 		$2.42M Sell
15,494
-5,598
-27% -$862K 0.01% 495
2022
Q1 		$3.28M Sell
21,092
-2,530
-11% -$367K 0.01% 468
2021
Q4 		$3.01M Buy
23,622
+7,166
+44% +$942K 0.01% 513
2021
Q3 		$2.14M Buy
16,456
+6,141
+60% +$928K 0.01% 569
2021
Q2 		$1.83M Buy
10,315
+3,267
+46% +$566K 0.01% 619
2021
Q1 		$1.16M Buy
7,048
+5,206
+283% +$857K ﹤0.01% 736
2020
Q4 		$304K Buy
+1,842
New +$274K ﹤0.01% 1082
2020
Q1 		– Sell
-1,703
Closed -$254K – 1079
2019
Q4 		$254K Buy
+1,703
New +$232K ﹤0.01% 990
2019
Q2 		– Sell
-4,425
Closed -$633K – 1186
2019
Q1 		$633K Buy
4,425
+1,132
+34% +$148K ﹤0.01% 790
2018
Q4 		$408K Sell
3,293
-8,953
-73% -$1.33M ﹤0.01% 833
2018
Q3 		$2.06M Sell
12,246
-1,312
-10% -$226K 0.01% 506
2018
Q2 		$2.34M Buy
13,558
+9,720
+253% +$1.59M 0.01% 438
2018
Q1 		$579K Buy
+3,838
New +$563K ﹤0.01% 801
2017
Q1 		– Sell
-16,220
Closed -$1.77M – 1057
2016
Q4 		$1.77M Buy
16,220
+6,663
+70% +$742K 0.01% 460
2016
Q3 		$1.16M Buy
+9,557
New +$1.29M ﹤0.01% 510

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CIBC World Market's JAZZ Position: Q1 2026 in Review

CIBC World Market reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.7% in Q1 2026, selling an estimated $7.86K and leaving 2,597 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #1135.

CIBC World Market first reported a position in JAZZ in Q3 2016 and has held it in 24 quarters since. The position peaked at $3.28M in Q1 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • CIBC World Market held 2,597 shares of Jazz Pharmaceuticals worth $491K as of Q1 2026.
  • CIBC World Market sold 45 Jazz Pharmaceuticals shares in Q1 2026, an estimated $7.86K.
  • Jazz Pharmaceuticals made up ﹤0.01% of CIBC World Market's portfolio in Q1 2026, its #1135 holding.
  • CIBC World Market first reported a position in Jazz Pharmaceuticals in Q3 2016 and has held it in 24 quarters since.
  • CIBC World Market's Jazz Pharmaceuticals position peaked at $3.28M in Q1 2022.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.